Virtual Reality in the Operating Room: Using Immersive Relaxation as an Adjunct to Anesthesia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Anesthesia, Intravenous
- Sponsor
- Beth Israel Deaconess Medical Center
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Intraoperative Propofol Dose
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This is a randomized, controlled trial designed to investigate whether the use of virtual reality immersive relaxation during hand/arm operations can allow for a relaxing operating room experience for patients while potentially reducing anesthesia requirements.
Detailed Description
The proposed study is a randomized, controlled trial to evaluate the effectiveness of VR as an adjunct to standard anesthetic practice for upper extremity surgery. Patients will be randomized to undergo immersion relaxation via the use of VR during their procedure or control. In both groups patients will undergo regional anesthesia preoperatively according to standard practice. Patients will then be assessed postoperatively to assess the intraoperative propofol dose between groups, as well as secondary outcomes including patient satisfaction.
Investigators
Brian O'Gara
Attending Anesthesiologist, Principal Investigator
Beth Israel Deaconess Medical Center
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing upper extremity (hand, wrist, arm, and/or elbow) surgery at BIDMC under MAC
Exclusion Criteria
- •Age \< 18
- •Open wounds or active infection of the face or eye area
- •History of seizures or other symptom linked to an epileptic condition
- •Patients who plan to wear hearing aids during the procedure
- •Patients with a pacemaker or other implanted medical device
- •Droplet or airborne precautions (as determined by BIDMC infection control policy)
- •Non-English speaking
- •Patients who require deep sedation
- •Patients who are deemed ineligible to approach by the surgeon
Outcomes
Primary Outcomes
Intraoperative Propofol Dose
Time Frame: 60 minutes
Total propofol dose (mg/kg/min) administered intraoperatively will be measured for the duration of the procedure.
Secondary Outcomes
- Other Intraoperative Anesthetics or Analgesics Administered(60 minutes)
- Length of PACU Stay(Duration of the patient's stay in the post anesthesia care unit, 100 minutes)
- Total Intraoperative Propofol Administered(60 minutes)
- Patient Survey: Agreement With the Following Statements (0-100)(PACU discharge)
- Difference Between Preoperative and Postoperative QuickDASH Scores(One month postoperatively)
- Pain Assessed by Eleven Point Numerical Rating Scale(Duration of stay in the post anesthesia care unit, 100 minutes)
- Overall Patient Satisfaction(PACU discharge)
- Hand Disability (QuickDASH)(One month postoperatively)